Global Ai In Oncology Market Size & Outlook
Global ai in oncology market, 2018-2030 (US$M)
Related Markets
Global ai in oncology market highlights
- The global ai in oncology market generated a revenue of USD 2,797.1 million in 2023 and is expected to reach USD 19,167.5 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 31.6% by 2030.
- In terms of segment, software solutions accounted for a revenue of USD 1,390.2 million in 2023.
- Software Solutions is the most lucrative component segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 2,797.1 million |
| Market revenue in 2030 | USD 19,167.5 million |
| Growth rate | 31.6% (CAGR from 2023 to 2030) |
| Largest segment | Software solutions |
| Fastest growing segment | Software Solutions |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software Solutions, Hardware, Services |
Other key industry trends
- In terms of revenue, the North America accounted for 42.1% of the global ai in oncology market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Canada is the fastest growing regional market and is projected to reach USD 1,829.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
AI In Oncology Market Scope
AI In Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global ai in oncology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai in oncology market will help companies and investors design strategic landscapes.
software solutions was the largest segment with a revenue share of 49.7% in 2023. Horizon Databook has segmented the Global ai in oncology market based on software solutions, hardware, services covering the revenue growth of each sub-segment from 2018 to 2030.
Developed countries, such as the U.S., Australia, Canada, and the UK, spend a large proportion of their GDP on healthcare. In these economies, the cost and demand for healthcare is growing rapidly, thus increasing the need for digital technologies, such as AI. In recent years, the U.S. and the UK have adopted AI technologies to reduce the cost of care and improve clinical services.
In addition, analytics coupled with AI technologies can significantly help in data mining of medical records. This may help in building an effective platform for healthcare processes such as drug discovery for cancer treatment. Furthermore, AI technology has multiple applications in oncology such as drug development designing, automated imaging, and AI surgical robots.
Therefore, increasing adoption of AI-based solutions in healthcare processes, especially for oncology for drug development and discovery, and rising number of strategic initiatives by healthcare technology giants are likely to fuel the market growth in the coming years.
Reasons to subscribe to Global ai in oncology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global ai in oncology market databook
-
Our clientele includes a mix of ai in oncology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global ai in oncology market , including forecasts for subscribers. This global databook contains high-level insights into Global ai in oncology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global ai in oncology market statistics, by regions, 2018-2030 (US$M)
Top 10 countries: Ai in oncology market size, 2023 (USD Million)
Top 10 countries: Ai in oncology market size, 2023 (USD Million)
Global ai in oncology market, by region, 2023 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
